| scholarly article | Q13442814 |
| P2093 | author name string | Torsten Kratz | |
| P2860 | cites work | Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology | Q22241632 |
| Snoezelen for dementia | Q22252979 | ||
| Memantine for dementia | Q22252980 | ||
| Aromatherapy for dementia | Q24200287 | ||
| Valproate preparations for agitation in dementia | Q24240034 | ||
| Donepezil for dementia due to Alzheimer's disease | Q24244938 | ||
| A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients | Q43827150 | ||
| Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease | Q44781866 | ||
| Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis | Q45023738 | ||
| A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances | Q45048773 | ||
| State of the art management of BPSD in dementia | Q45212208 | ||
| Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses | Q46920921 | ||
| Behavioural and psychological symptoms in general hospital patients with dementia, distress for nursing staff and complications in care: results of the General Hospital Study. | Q47998161 | ||
| What is reminiscence therapy? | Q51868674 | ||
| A placebo-controlled double-blind randomized study of venlafaxine in the treatment of depression in dementia. | Q51903766 | ||
| [Do German World War II victims fulfill PTSD-criteria?]. | Q51976083 | ||
| A double-blind, randomized, fixed-dose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer's disease. | Q52001900 | ||
| Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial. | Q52009507 | ||
| The Empirical Behavioral Pathology in Alzheimer's Disease (E-BEHAVE-AD) Rating Scale. | Q52010407 | ||
| Incidence and importance of "non-cognitive" symptoms in dementia of the Alzheimer type: productive psychotic symptoms, depressive disorders and behavioral disorders | Q52061994 | ||
| Relationship between Helicobacter pylori infection and Alzheimer disease. | Q53378097 | ||
| [Poststroke depression: risk factors and effects on the course of the stroke] | Q73024492 | ||
| A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia | Q73382255 | ||
| Validation theory and the myth of the therapeutic lie | Q79981670 | ||
| Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium | Q29614409 | ||
| A New Depression Scale Designed to be Sensitive to Change | Q29614720 | ||
| Calming music and hand massage with agitated elderly. | Q30331994 | ||
| Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. | Q30351745 | ||
| Efficacy of music therapy in the treatment of behavioral and psychiatric symptoms of dementia. | Q30369751 | ||
| Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials | Q33153605 | ||
| Tailored activities to manage neuropsychiatric behaviors in persons with dementia and reduce caregiver burden: a randomized pilot study | Q33576989 | ||
| Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus | Q33699361 | ||
| Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study | Q33930367 | ||
| Rivastigmine for dementia associated with Parkinson's disease | Q33983707 | ||
| Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. | Q34104256 | ||
| Potentially inappropriate medications in the elderly: the PRISCUS list | Q34104787 | ||
| Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture | Q34268922 | ||
| Haloperidol for agitation in dementia. | Q34424821 | ||
| The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update | Q34603491 | ||
| Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials | Q34651137 | ||
| Challenges in conducting qualitative research with individuals with dementia | Q34792866 | ||
| Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale | Q35154789 | ||
| Treating Apathy in Alzheimer’s Disease | Q35561918 | ||
| Preventing postoperative delirium | Q35675973 | ||
| Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD. | Q35846062 | ||
| Creating a multisensory environment for dementia: the goals of a Snoezelen room | Q36302645 | ||
| Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial | Q37271450 | ||
| Supporting Families Living With Dementia in Rural Areas | Q37483593 | ||
| Management of agitation and aggression associated with Alzheimer disease | Q37504709 | ||
| Pain treatment of agitation in patients with dementia: a systematic review | Q37838847 | ||
| The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia | Q39605807 | ||
| Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials. | Q39675765 | ||
| A prospective study of the effects of behavioral symptoms on the institutionalization of patients with dementia | Q40386005 | ||
| An observational study of agitation in agitated nursing home residents | Q41257623 | ||
| Life-span perspective of personality in dementia | Q41296615 | ||
| A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease | Q42538346 | ||
| Efficacy and tolerability of carbamazepine for agitation and aggression in dementia | Q42545594 | ||
| Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial | Q42930136 | ||
| A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia | Q43632183 | ||
| P433 | issue | 26 | |
| P921 | main subject | dementia | Q83030 |
| diagnosis | Q16644043 | ||
| P304 | page(s) | 447-454 | |
| P577 | publication date | 2017-06-01 | |
| P1433 | published in | Deutsches Ärzteblatt international | Q27722165 |
| P1476 | title | The Diagnosis and Treatment of Behavioral Disorders in Dementia | |
| P478 | volume | 114 |
| Q47096873 | Additional Comments |
| Q89220295 | Dementia Care at End of Life: Current Approaches |
| Q94411590 | In Reply |
| Q47098229 | Paying Attention to Electrolytes |
| Q50073941 | Provision of palliative care for people with advanced dementia |
| Q92888309 | Psychopharmacological Treatment in Older People |
| Q90629692 | The Prevalence of Dementia and Cognitive Impairment in Hospitals |
Search more.